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INTRODUCTION
After the influenza A H1N1 epidemics, the use of
extracorporeal membrane oxygenation (ECMO) has increased
worldwide. The goal of respiratory ECMO support is to
improve hypoxemia and hypercapnia, allowing protective
mechanical ventilation to avoid further ventilator-associated
lung injury (1). The current literature supports improved
outcomes using ECMO in severe lung injury patients. In
Brazil, few hospitals are able to provide respiratory ECMO
support, and there is no transfer system (2).
The aim of this manuscript was to present and discuss
two cases of severe respiratory failure supported with
ECMO.
CASE DESCRIPTION 1
A previously healthy 27-year-old man was admitted to a
tertiary hospital in Guarulhos, Sa˜o Paulo, with a diagnosis
of severe community-acquired pneumonia. Three days later,
his clinical status deteriorated, and mechanical ventilation
was initiated due to severe hypoxemic respiratory failure.
Prone positioning and alveolar recruitment were attempted
without success. Pneumothorax with a bronchopleural
fistula complicated the clinical status, and the ECMO team
from Hospital das Clı´nicas, Sa˜o Paulo, Brazil, was called. A
team consisting of one physician, one intensive care fellow,
one registered respiratory therapist, and one registered
nurse was sent to assess the patient. During the evaluation,
the patient was found to have sustained pulse oximetry of
52%, an arterial partial pressure of oxygen (PaO2) of
43 mmHg and an arterial partial pressure of CO2 (PaCO2)
of 142 mmHg, with an inspired fraction of oxygen (FiO2) of
1 and optimized mechanical ventilation. There were no
signs of hemodynamic compromise. Venous-venous ECMO
support was initiated. The initial parameters were set at an
oxygen flow (sweeper) of 6 L/min and a blood flow of 6 L/
min. Ventilation was adjusted to pressure control mode,
with a peak inspiratory pressure of 20 cmH2O, a positive
end-expiratory pressure of 10 cmH2O, a respiratory rate of
10 breaths per minute and an FiO2 of 0.3. After stabilization,
the patient was transferred to Hospital das Clı´nicas 27 km
away in an ICU ambulance transport. The entire process,
from initial call to arrival at Hospital das Clı´nicas, lasted 10
hours. The clinical and arterial blood gas data during the
ICU stay are shown in Table 1. A chest radiograph is shown
in Figure 1a.
Twenty-four hours after arrival at Hospital das Clı´nicas,
the patient’s pupils became bilaterally dilated, and he lost
brainstem reflexes in the absence of sedation, a clinical
finding compatible with brain death. An apnea test was
performed while the patient was normothermic with a mean
arterial blood pressure of 86 mmHg by setting the ECMO to
provide a pulse oximetry of at least 90% with the lowest
sweeper flow setting. Mechanical ventilation was with-
drawn, and continuous oxygen was supplied through the
tracheal tube to prevent hypoxia. Close monitoring for
respiratory movements was performed for 10 minutes. An
arterial blood analysis was performed before and after
the test to detect an increase in PaCO2 (Table 2). The
neurological tests were repeated six hours later according to
the Brazilian laws regulating the diagnosis of brain death.
Transcranial Doppler ultrasonography indicated cerebral
circulatory arrest, and computed tomography showed
diffuse brain edema, brainstem herniation, and multiple
foci of hemorrhage (Figure 2). Thus, ICU support was
withdrawn.
CASE DESCRIPTION 2
A 42-year-old female with a previous history of illicit
drug use was admitted to a tertiary hospital in Guarulhos,
Sa˜o Paulo, at 10 days postpartum with the diagnosis of
community-acquired pneumonia. Five days later, she
developed respiratory failure requiring mechanical ventila-
tion and was transferred to the ICU. Two days later, her
respiratory status deteriorated, with persistent hypoxemic
and hypercapnic respiratory failure, and the ECMO
response team from Hospital das Clı´nicas was called.
The patient had a peripheral oxygen saturation of 80%
and a PaCO2 of 80 mmHg without hemodynamic compro-
mise. Mechanical ventilation was set at a PEEP of
10 cmH2O, an FiO2 of 1, and a peak pressure of
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35 cmH2O. Venous-venous ECMO support was initiated.
Her blood gas parameters improved after ECMO support,
and the patient was transferred by helicopter. The entire
process, from the initial call to arrival at Hospital das
Clı´nicas, lasted four hours. The chest radiograph acquired in
our hospital is shown in Figure 1b.
During the first two days after cannulation, the patient
was sedated with propofol and fentanyl, with a Sedation-
Agitation Scale ranging from 2 to 5 due to drug abstinence.
Ventilation was set in pressure support mode with a
positive-end expiratory pressure of 10 cmH2O, a pressure
support of 8 cmH2O, and an FiO2 of 0.3. The ECMO settings
were adjusted to achieve a PaO2.50 mmHg.
The patient improved gradually (Table 3), and after seven
days of extracorporeal support, she was awake and
cooperative. Daily weaning tests from ECMO support were
conducted in accordance with our criteria for ECMO
discontinuation. ECMO was stopped nine days after
initiation. Mechanical ventilation was discontinued two
days later. The patient was discharged from the hospital 33
days after admission with no functional disability.
DISCUSSION
The use of ECMO in adult patients has increased after the
influenza A H1N1 outbreak. During the H1N1 epidemics,
two observational studies reported a mortality rate of 20%
with ECMO support compared to the expected 50%
mortality in conventionally supported patients (3,4).
Additionally, in patients with severe lung injury, the
CESAR trial showed that 63% of patients supported with
an ECMO-including strategy survived without disability for
six months compared to 47% of those allocated to conven-
tional support (1).
Table 1 - Clinical data and arterial blood gases (Case 1).
Data Pre-ECMO Day 1 Day 2 Day 3
Mechanical ventilation
Ventilatory mode PCVI PCVI PCVI PCVI
Peak pressure (min–
max) - cmH2O
25 22 24
PEEP (min–max) - 12 10 10
cmH2O
£ 0.5 0.5 0.6
FIO2 (minmax)
¥ 20–54 20-22 20-24
Respiratory rate (min–
max) - breaths/min
ECMO J
3.3–6.4 4.49-4.79 4.58-7.9
Blood flow (min–max)
- L/min
10 6-10 8
Sweeper flow (min–
max) - L/min
1.0 1.0 1.0
FIO2
Routine blood gas 48.5 44.8 57
PaO2 - mmHg 40.3 44.3 22.6
PaCO2 - mmHg 8.4 -6.5 -13.3
SBE - mEq/L * 7.51 7.27 7.30
pH
Patient data 1 1 1
SAS (min–max)# 2.75 2.5 2.5
Lung injury score " 8 18 19
Total SOFA score 1 4 4 4
Respiratory SOFA 0 4 2
Cardiovascular SOFA 0 0 3
Hematological SOFA 2 2 2
Hepatic SOFA 2 4 4
Neurological SOFA 0 4 4
Renal SOFA
*SBE denotes standard base excess.
#SAS denotes the Sedation-Agitation Scale.
1SOFA denotes sequential organ failure assessment. This score is used to
diagnose and quantify organ failure, and it ranges from 0 to 24.
"The lung injury score is Murray’s score, which quantifies the severity of
lung injury based on the respiratory compliance, PEEP, number of
quadrants infiltrated on a chest X-ray and PaO2/FIO2 ratio.
IPCV denotes pressure-controlled ventilation.
£PEEP denotes positive end-expiratory pressure.
¥FiO2 denotes the inspiratory fraction of oxygen.
JECMO denotes extracorporeal membrane oxygenation.
Figure. 1A - Chest X-Ray after installation of ECMO in patient 1.
1B: Chest X-Ray after installation of ECMO in patient 2
Table 2 - Arterial blood gases during the apnea test in
patient 1.
1˚ test 2˚ test
Pre Post Pre Post
pH 7.303 7.072 7.319 7.141
PaO2 67.0 mmHg 61.2 mmHg 100.3 mmHg 66.3 mm Hg
PaCO2 50.3 mmHg 87.3 mmHg 44.4 mmHg 73.0 mm Hg
Saturation 90.5% 77.1% 97.0% 84.2%
Bicarbonate 24.3 mmol/L 24.9 mmol/L 22.3 mmol/L 24.3 mmol/L
SBE* -2.6 mmol/L -7.5 mmol/L -3.9 mmol/L -6.3 mmol/L
Lactate 21 mg/dL 24 mg/dL 25 mg/dL 24 mg/dL
*SBE denotes standard base excess.
Figure 2 - A e B: CT scan demonstrating diffuse cerebral edema
with ventricular and sulcal effacement in case 1.
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Patient transfer
Most studies involving transfer to referral centers during
ECMO opted to transfer the patient in conventional
mechanical ventilation before starting ECMO support
(1,3). However, this type of transferinvolves considerable
risk, and deaths have been described during the process (1).
Conversely, previously published data show the safety and
feasibility of the inter-hospital transport of critically ill
adults under ECMO support (5,6). After implementing a
protocol for the safe transport of adults on ECMO, Forrest
et al. described the transportation of 40 patients without
deaths or major morbidity (6). In another study, transporta-
tion under ECMO support was associated with fewer
episodes of hypoxia compared to patients transported
under conventional ventilation (7). In both of our cases,
we chose to initiate ECMO support before patient transfer to
assure safer transport. There were no adverse events during
transportation between the hospitals.
The optimal timing for ECMO initiation is not well
established. Both of the patients described in this report
were transferred from the same hospital in the city of
Guarulhos. In the first case, ECMO was started several days
after intubation, while the second patient was cannulated
early after the diagnosis of severe respiratory failure.
Because there is no organized referral system between our
services, it is reasonable to presume that the first successful
transport may have encouraged faster contact for the second
patient. As previously reported by Forrest et al. (6), we
believe that the development of a referral and transfer
program is associated with faster ECMO initiation, safer
transportation and, possibly, a higher rate of survival.
We propose the algorithm described in Figure 3 to create
a transfer program for ECMO patients. As described in this
report, earlier ECMO initiation is most likely associated
with higher rates of survival. Therefore, we believe that a
low threshold of hypoxemia despite optimal therapy should
be sufficient to trigger an ECMO specialist consultation. The
classical criteria for ECMO initiation should not be used as a
trigger for consultation because it may adversely hinder
support. In the presence of critical but reversible lung injury
with no contraindication for extracorporeal support, an
ECMO team (composed of two physicians and one
registered nurse) would be responsible for the evaluation
of the patient on location and, if indicated, ECMO support
initiation. Because ECMO is a highly complex technique that
involves high costs, constant personnel training and high
complication rates (8), referral centers should be reserved
for tertiary care centers only.
Brain death diagnosis during ECMO support
Neurological injury is common in ECMO-supported
patients. It is uncertain whether the extracorporeal support
may precipitate injury or if the patient’s morbid condition is
the only responsible factor (9). A study of 295 patients from
the ELSO registry for whom ECMO was used to support
cardiopulmonary resuscitation reported brain death in 28%
of non-survivors (10) More recently, ECMO support to
maintain potential organ donors has been used to increase
the donor pool (11).
Performing an apnea test in ECMO-supported patients is
a major challenge because ECMO support is able to
maintain normal blood gases in apneic patients. In case 1,
we decided to disconnect the patient from the ventilator and
then set the sweeper flow to the lowest level necessary to
achieve a pulse oximetry of 90%. Respiratory movements
were monitored, and blood gas analyses were obtained
before and 10 minutes after a stable sweeper flow was
initiated to detect an increase in the carbon dioxide partial
pressure. Muralidharan et al. (12) reported three cases of
possible brain death in ECMO patients in which the apnea
test was not performed due to the lack of standardized
procedures. However, they suggested that patients should
remain connected to the ventilator under continuous
positive airway pressure with a PaCO2 between 35–
45 mmHg. Subsequently, they suggested that the sweeper
flow be set to the minimum value compatible with normal
pulse oximetry before the test. We adopted a similar
procedure.
ECMO is a specialized technique and a lifesaving
measure when other rescue therapies have failed. The
treatment of patients under ECMO support must be
performed in referral centers with a trained ECMO team.
The transfer of patients seems plausible and safe. Despite
recent advances and continuous training, there are still
Table 3 - Clinical data and arterial blood gases (Case 2).
Data Pre-ECMO Day 1 Day 2 Day 5 Day 10
Mechanical ventilation
Ventilatory mode PCVI PCVI PCVI PSV2 PSV2
Peak pressure (min–max)
- cmH2O
25
10
25
15
25
15
20
13
PEEP (min–max) -
cmH2O £
0.6 0.3 0.3 0.6
FIO2 (min–max) ¥ 15-21 19-28 16-36 14-42
Respiratory rate (min–
max) - breaths/min
ECMO J
3.02- 4.48-
6.62
4.05- 3.67-
Blood flow (min–max) -
L/min
5.33 6 5.08 3.84
Sweeper flow (min–
max) - L/min
6–7 1.0 3-4.5 0.5
FIO2 1.0 1.0 1.0
Routine blood gas 66.3
PaO2 - mmHg 51.4 42.4 52 79.8
PaCO2 - mmHg 40.6 +1.9 33 57.3
SBE - mEq/L * -0.6 7.41 +6.1 +6.6
pH 7.39 7.41 7.38
Patient data 2–6
SAS (min – max)# 2 2.5 3-5 4
Lung injury score " 3 6 2.75 2.5
Total SOFA score 1 6 4 8 4
Respiratory SOFA 4 0 4 4
Cardiovascular SOFA 0 0 2 0
Hematological SOFA 0 0 0 0
Hepatic SOFA 0 2 0 0
Neurological SOFA 2 0 2 0
Renal SOFA 0 0 0
*SBE denotes standard base excess.
#SAS denotes the Sedation-Agitation Scale.
1SOFA denotes sequential organ failure assessment. This score is used to
diagnose and quantify organ failure, and it ranges from 0 to 24.
"The lung injury score is Murray’s score, which quantifies the severity of
lung injury based on the respiratory compliance, PEEP, number of
quadrants infiltrated on a chest X-ray and PaO2/FIO2 ratio.
IPCV denotes pressure-controlled ventilation.
2PSV denotes pressure-support ventilation
£ PEEP denotes positive end-expiratory pressure.
¥FiO2 denotes the inspiratory fraction of oxygen.
JECMO denotes extracorporeal membrane oxygenation.
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many uncertainties in the management of this specific
population.
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